MedTrace Logo

h.Pylori Ttt With Rebamipide

NCT04550858 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-09-16

No results posted yet for this study

Summary

the primary aim is specially in resistant cases of H.pylori and in promotion of peptic ulcer

Conditions

  • H.Pylori Infection

Interventions

DRUG

Rebamipide

rebamipide use for ttt of h.pylori infection

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-05
Primary Completion
2021-08-21
Completion
2021-09-21

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04550858 on ClinicalTrials.gov